Ronan Brown
Direttore operativo presso ConcertAI LLC
Profilo
Ronan Brown is currently the Chief Operating Officer at ConcertAI LLC since 2022.
Prior to this, he worked as a Director at Anaborex, Inc. and held Principal positions at Minerva Ltd., BRI International, Inc., and Glaxo Wellcome, Inc. He also worked as a Principal at Quintiles, Inc. (California) from 1999 to 2009.
Dr. Brown completed his undergraduate degree at The University of Southampton and his doctorate at the University of London.
Posizioni attive di Ronan Brown
| Società | Posizione | Inizio |
|---|---|---|
ConcertAI LLC
 ConcertAI LLC Information Technology ServicesTechnology Services ConcertAI LLC engages in the provision of definitive real-world data and AI solutions for precision oncology. The firm focuses on revolutionizing clinical and outcomes research to accelerate the insights benefitting patient treatment. It offers clinical development, medical, market access, commercial and patient solutions. The company is headquartered in Boston, MA. | Direttore operativo | 15/11/2022 |
Precedenti posizioni note di Ronan Brown
| Società | Posizione | Fine |
|---|---|---|
Anaborex, Inc.
 Anaborex, Inc. Medical/Nursing ServicesHealth Services Anaborex, Inc. provides clinical research services for metabolic diseases. The company develops drugs for the treatment of cancer related wasting syndrome. It was founded in 2005 by Alan Saven and Jorge Nieva and is located in La Jolla, CA | Direttore/Membro del Consiglio | 31/12/2012 |
Minerva Ltd.
 Minerva Ltd. Real Estate DevelopmentFinance Minerva Ltd. is a property investment and development company. The firm has a number of real estate developments; all located in the Greater London area, comprising city office, high-end residential and mixed-use schemes. The company was founded by David Garrard and Andrew Rosenfeld in 1988 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
Quintiles, Inc. (California)
 Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | - |
| Glaxo Wellcome, Inc. | Corporate Officer/Principal | - |
BRI International, Inc.
 BRI International, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Quintiles Transnational Corp., BRI International, Inc. is a pharmaceutical research and development company with 445 employees. The company is based in Arlington, VA. BRI International was acquired by Quintiles Transnational Corp. on November 22, 1996 for $130.63 million. The company was founded by Harold Solomon. | Corporate Officer/Principal | - |
Formazione di Ronan Brown
| The University of Southampton | Undergraduate Degree |
| University of London | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Quintiles, Inc. (California)
Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Health Services |
Anaborex, Inc.
Anaborex, Inc. Medical/Nursing ServicesHealth Services Anaborex, Inc. provides clinical research services for metabolic diseases. The company develops drugs for the treatment of cancer related wasting syndrome. It was founded in 2005 by Alan Saven and Jorge Nieva and is located in La Jolla, CA | Health Services |
Minerva Ltd.
Minerva Ltd. Real Estate DevelopmentFinance Minerva Ltd. is a property investment and development company. The firm has a number of real estate developments; all located in the Greater London area, comprising city office, high-end residential and mixed-use schemes. The company was founded by David Garrard and Andrew Rosenfeld in 1988 and is headquartered in London, the United Kingdom. | Finance |
BRI International, Inc.
BRI International, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Quintiles Transnational Corp., BRI International, Inc. is a pharmaceutical research and development company with 445 employees. The company is based in Arlington, VA. BRI International was acquired by Quintiles Transnational Corp. on November 22, 1996 for $130.63 million. The company was founded by Harold Solomon. | Commercial Services |
| Glaxo Wellcome, Inc. | Health Technology |
ConcertAI LLC
ConcertAI LLC Information Technology ServicesTechnology Services ConcertAI LLC engages in the provision of definitive real-world data and AI solutions for precision oncology. The firm focuses on revolutionizing clinical and outcomes research to accelerate the insights benefitting patient treatment. It offers clinical development, medical, market access, commercial and patient solutions. The company is headquartered in Boston, MA. | Technology Services |
- Borsa valori
- Insiders
- Ronan Brown
